Severe asymptomatic maternal antepartum hyponatremia leading to neonatal seizures: prevention is better than cure by unknown
CASE REPORT Open Access
Severe asymptomatic maternal antepartum
hyponatremia leading to neonatal seizures:
prevention is better than cure
Enrico Valerio*, Margherita Fantinato, Irene Alba Beatrice Giovannini, Eugenio Baraldi and Lino Chiandetti
Background: Pre-delivery maternal electrolyte derangements may reflect themselves in the newborn, since
placental homeostasis determines electrolyte equilibrium between mother and fetus.
Case presentation: A term newborn, transferred to our Neonatal Intensive Care Unit 1 h after birth for an apnoea
episode, presented with initially left-sided, and subsequently generalized tonic-clonic seizures due to severe
hyponatremia (119 mmol/L). Seizures rapidly ceased after electrolyte correction plus a phenobarbital bolus. Deep
hyponatremia was also detected in the mother (123 mmol/L).
Conclusions: As placental homeostasis determines electrolytes equilibrium between mother and fetus, obstetrics
and neonatologists should be aware that any maternal dyselectrolytemia will reflect itself in the newborn; hence, it
is fundamental to detect possible maternal electrolyte imbalances before delivery, in order to be prepared to timely
correction of electrolyte derangements in the newborn.
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Background
Placenta represents the key organ for maternal-fetal
interaction all along pregnancy. Apart from its role in
delivering nutrients to and removing waste products
from the fetus -as well as its endocrine functionalitypla-
centa also controls micronutrient, trace element, and
electrolyte transfer from mother to fetus and vice versa,
maintaining homeostatic equilibrium between the two
circulations. Pre-delivery maternal electrolyte derange-
ments may reflect themselves in the newborn, since pla-
centalhomeostasis determines electrolyte equilibrium
between mother and fetus.
Case report
A term neonate was born on vaginal, non-underwater
delivery at 39 + 6 weeks. Obstetric history was remark-
able for gestational diabetes controlled with diet therapy.
The mother wasn’t under any medications. During
labor –which lasted 17 h- she was administered paren-
teral hydration with 5 % dextrose, with liberalized oral
water intake which was not quantifiable. No oxytocin
or other medications were administered. Maternal
blood pressure was normal before delivery; no other
signs of pre-eclampsia were noted.
Delivery was substantially uneventful, except for lightly
meconium-stained amniotic fluid. Apgar index was nine
at first and ten at fifth minute. Neonatologists were not
called to assist at delivery.
Umbilical cord blood gas analysis performed in deliv-
ery room showed severe hyponatriemia (sodium
117.8 mmol/L). Other electrolytes were normal. No elec-
trolyte correction was started at this point, and the baby
was given to the mother to begin skin-to-skin contact.
One hour after birth, while lying on her mother’s
breast, the baby presented an apnoea episode for which
neonatologists were called; at evaluation the baby pre-
sented normal air entry with expiratory grunting and O2
saturation ranging from 80 to 85 % in room air. On
these basis and given the anamnestic data of meconium-
stained amiotic fluid, the baby was admnistered nasal
continuous positive air pressure with O2 saturation rise
to 98 %, and then transferred to our Neonatal Intensive
Care Unit (NICU) to start intravenous antibiotic therapy.
During umbilical vein incannulation procedure, the
baby presented initially left-sided, and subsequently
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generalized tonic-clonic seizures. A rapid blood glucose
test was obtained, showing normoglycemia (96 mg/dl); a
venous blood gas analysis was performed, showing deep
hyponatremia (sodium 119 mEq/L) and mild hypocalce-
mia (ionized calcium 1.15 mmol/L), both subsequently
confirmed by laboratory analysis. Rapid electrolyte correc-
tion with two sodium chloride boluses (2 mEq/kg each, in
5 min) and one calcium gluconate bolus (0.3 mEq/kg, in
10 min, under ECG monitoring) was undertaken, along
with a phenobarbital bolus (20 mg/kg, in 20 min). Seizures
rapidly ceased; normal reactivity and crying were present
2 h later. Blood gas analysis undertaken 1 h after seizures
start showed a sodium level of 124.4 mmol/L, which was
considered a safe threshold; from that moment on, slow
sodium intravenous supplementation (pure sodium chlor-
ide [concentration 2 mmol/ml], diluted with distilled
water for IV use) was then started and maintained for the
next 24 h. Following seriated blood gas analyses showed
stabilization of sodium levels around 124 mmol/L for the
next 6 h; then, blood sodium showed a steady rise and
reached a new stabilization around 140 mmol/L about
20 h after the reaching of the “safe threshold” of 124.4.
Based on this data, hyponatremia was corrected at the ap-
proximate velocity of 0.78 mmol/L/h.
Immediately after seizures resolution, a cerebral ultra-
sound was performed: no sign of edema, intracranial bleed-
ing, or other structural anomalies were evident. Overnight
cerebral function monitoring (CFM) was then started,
showing no sign of gross electrical abnormalities. Electro-
encephalogram (EEG) was performed 12 h after initial
symptoms, showing no pathological features; phenobarbital
was then discontinued without seizure relapse.
No fluid restriction was employed during sodium cor-
rection; the baby was fed with normal term formula.
Urinary electrolyte excretion fraction calculated at
36 h of life was normal; blood urea nitrogen and creatin-
ine were normal.
C-reactive protein was permanently negative during
admission. Birth hemoculture turned out negative.
One-month post-discharge follow up visit showed nor-
mal neurodevelopment.
An anamnestic supplement, obtained some hours after
neonatal symptoms onset, revealed severe asymptomatic
maternal hyponatremia (123 mmol/L at a blood sam-
ple drawn 4 h before delivery), corrected only several
hours after delivery. A maternal blood sample drawn
24 h after delivery showed normal plasma sodium




Neonatal seizures always require rapid correction in
order to prevent permanent cerebral damage. Neonatal
period is the one at highest risk for seizures (1.8-5/1000
live births in the US); relative incidence is higher in
preterm (3.9 %) compared to term babies (1.5 %) [1].
Neonatal seizures’ etiology, semiology, and electroen-
cephalographic features are peculiarly different from
those of other age groups, and can be refractory to
commonly used antiepileptic drugs.
Loman et al. [2] classified neonatal seizures etiology into
hypoxic-ischemic encephalopathy, ischemic infarction,
intracranial hemorrhage, intracranial infections, metabolic
or electrolyte disorders, congenital malformations of the
central nervous system, inborn errors of metabolism, in-
toxications and epileptic syndromes. In the setting of
emergent, clinically unmistakable neonatal seizures with
no available anamnestic clues on etiology, a symptom-
based, stepwise rapid diagnostic-therapeutic algorhythm is
advisable. A blood gas analysis should be obtained imme-
diately in order to assess electrolyte and glucose status of
the newborn, followed by rapid correction if needed. If no
alterations in blood electrolytes or glucose are found, or if
rapid metabolic correction is not yet sufficient to control
seizures, antiepileptic drugs should be used: current prac-
tice includes first line therapy with phenobarbital (loading
dose 20–40 mg/kg) [3], followed by phenytoin and/or
benzodiazepines such as lorazepam (0.05– 0.1 mg/kg) as
second line therapy to treat refractory seizures [4]. Once
symptoms are under control, a thorough diagnostic work-
up (including cerebral ultrasonography and/or magnetic
resonance imaging, electroencephalogram, microbiology
tests, laboratory ammonium and lactate) must be under-
taken to assess other known causes of neonatal seizures. A
detailed description of delivery will help in define hypoxic-
ischemic encephalopathy-related seizures, requiring neu-
roprotection with beginning of neonatal hypothermia
within 6 h from birth [5].
Neonatal hyponatremia
Neonatal electrolyte disorders account for 10 % of sei-
zures at birth; [2] mild hyponatremia, defined as a serum
concentration of sodium of <133–135 mEq/L, occurs in
25 % of ill newborns, while moderate hyponatremia
(sodium <130 mEq/L) occurs in 1 % [6].
Physiopathology of seizures secondary to hyponatre-
mia recognizes an increase of cerebral water which, if
acute (ie, acute hyponatremia) leads to cellular edema
and subsequent encephalopathy, seizures, respiratory ar-
rest, and coma. On the contrary, chronic hyponatremia
is better tolerated because of the brain capability to pro-
duce the so-called idiogenic osmoles, with tend to
normalize intracellular water content [7]. Chronic hypo-
natremia may in turn be associated to poor neonatal
growth [8] and/or to sensorineural hearing loss.
Typically, newborns develop hyponatremia due to ex-
cessive renal sodium loss and/or kidney inability to
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excrete free water; in addition, hyponatremia may be
sustained by high neonatal vasopressin levels [6].
Basing on plasma osmolarity, hyponatremia in
newborns can be classified into hysotonic (280–
295 mOsm/L; extremely rare in the newborn and
generally due to laboratory errors, although possibly
caused by rise of plasmatic lipids or proteins), hypertonic
(>295 mOsm/L; occasionally found in newborns, par-
ticularly those with concomitant hyperglycemia), and
hypotonic (<280 mOsm/L; the most frequent form in
newborns, furtherly classified into three subcategories
according to patient’s extracellular fluid volume status:
hypovolemic, euvolemic and hypervolemic) [6].
According to time of onset, neonatal hyponatremia
can be classified into acute (onset within 48 h) and
chronic (developing after more of 48 h).
Acute hyponatremia, in our case, reflected maternal
pre-delivery hyponatremia (probably induced by excessive
hydration during labor). Neonatal serum electrolytes in
the first hours of life reflect indeed those of mother, since
microelements tend to balance across placental interface.
Other causes of neonatal hyponatremia include continu-
ous glucagon infusion [9], accidental administration of
oxytocin [10], congenital hypothyroidism [11], and con-
genital adrenal hyperplasia [12].
Causes of maternal hyponatremia include excessive
oral water intake during labour [13, 14], iatrogenic ma-
ternal fluid overload [15, 16], maternal medications like
oxytocin, diuretics, ACE inhibitors, antidepressants like
selective serotonin reuptake inhibitors [SSRI’s], synthetic
recreational drugs like ecstasy.
In our case, the first maternal blood sodium available
(123 mEq/L) was obtained during labor and was already
extremely low; unfortunately, maternal blood sodium
value before labor commencement was not available.
The woman was always asymptomatic; her blood sodium
value rose to and remained stable at around 140 mmol/L
after maternal sodium correction, which indirectly sug-
gests the absence of maternal conditions predisposing to
hyponatremia.
Conclusions and final remarks
What should the Neonatologist retain
Neonatal seizures are always an emergent issue in
NICUs. First line diagnostics should include a blood gas
analysis and a blood glucose test, with following appro-
priate correction if indicated; antiepileptic drugs should
be started if seizures don’t cease despite metabolic de-
rangements correction, and therapeutic hypothermia ini-
tiated if appropriate.
Further diagnostics should include cerebral ultrasound
and/or magnetic resonance imaging, electroencephalo-
gram, microbiology tests, laboratory ammonium and lac-
tate to assess other known causes of neonatal seizures.
In the event of acute hyponatremia-related seizures,
rapid sodium correction is mandatory since the risk of
sequelae is greater than that of myelinolysis; according
to most Authors, plasma sodium should be raised
quickly until 125 mmol/L (or, anyhow, blood sodium
target must be that which allows the patient to become
asymptomatic) and then corrected slowly (not more than
8–10 mmol/L in the first 24 h –i.e., 0.3–0.4 mmol/L/h) to
avoid both cerebral oedema and the risk of myelinolysis)
[6], with at least two-hourly monitoring of sodium levels.
Although little evidence-based information on the appro-
priate rate at which to correct severe hyponatremia in ne-
onates exist, previously cited velocities of blood sodium
correction (0.3–0.4 mmol/L/h) [6] seem consistent with
guidelines about rapid correction of severe hyponatremia
in older children, which suggest a maximum correction
velocity for blood sodium of 0.5 mmol/L/h [17].
Fluid restriction should also be undertaken as a cor-
rective measure of hyponatremia in the term newborn if
history suggests low blood sodium secondary to mater-
nal water intoxication; this is supported by the observa-
tion that these newborns manifest an excess weight loss
after birth when compared to isonatriemic newborns
[15]. On the contrary, fluid restriction is not to be con-
sidered as a first line treatment for hyponatremia of low
birth weight [LBW] and very low birth weight [VLBW]
preterm newborns: these patients in fact recognize dif-
ferent mechanisms leading to hyponatremia, such as in-
creased sodium demand (particularly in the “catch up”
growth phase) and increased sodium renal losses due to
immature tubular function [18].
In order to prevent hyponatremia in these patients, IV
sodium supplementation start should actually be consid-
ered when blood sodium becomes lower than 140 mmol/
L, which usually occurs on day of life two or three; then, a
minimum of 4 mmol/kg/die sodium supplementation is
warranted to grant an adequate growth. Other possible so-
dium losses (eg, nasogastric tube, stomies, surgical drain-
ages) also must be considered and replaced [18].
On the contrary, healthy term newborn do not rou-
tinely need sodium supplementation due to renal tubule
maturation, which grants a much better hydroelectroly-
tic homeostasis for these patients. Newborn outcomes of
symptomatic hyponatremia include convulsions, apnoea,
cyanotic spells, respiratory distress, feeding difficulty,
and excess weight loss after birth; [15] several reports
anyway describe a generally good long-term neurologic
outcome in these patients [13, 14, 19] – provided that
hyponatremia is rapidly detected and treated as the
underlying cause of neonatal seizures.
What should the obstetric retain
Several randomized trials [20–23] have established that
the routine administration of oral and/or IV fluids to
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keep women adequately hydrated during labour may re-
duce the period of contraction and relaxation of the
uterine muscle, and may ultimately reduce the duration
of the labour. Labor patients hydration protocols, any-
way, are extremely variable from Centre to Centre. A re-
cent systematic review [24] based on nine randomized
trials with 1781 women does not provide robust evi-
dence to recommend routine administration of intraven-
ous fluids. Additionally, in trials where oral fluids were
not restricted there was considerable variation in the
amount of oral fluid consumed by women in different
arms of the same trial, and between different trials [24].
What is clear is that, when a more than mild hypona-
tremia is detected in pregnant women at pre-delivery
blood tests, a thorough maternal history should be
taken about hydration status, sodium-active drugs use
(diuretics, ACE inhibitors, antidepressants like SSRI’s,
synthetic recreational drugs like ecstasy), sodium-affecting
pathologies (heart failure, adrenal insufficiency, renal fail-
ure, hypothyroidism, cystic fibrosis).
Labor hydration itself (particularly if conducted with
sodium-free solutions like 5 % or 10 % dextrose) can
lead to acute hyponatremia in previously normosodiemic
women; [15] consequently, even in women who have
normal blood sodium at admittance, a basal sodium sup-
plementation should be given along with IV or oral hy-
dration during labor, in order to prevent iatrogenic
maternal (and consequently, neonatal) hyponatremia.
Obstetric must also be aware that neonatal hypona-
tremia has also been reported with underwater births
[25–27].
Feto-maternal equilibrium through placental homeo-
stasis is a well-established concept, so Obstetrics must
be aware that any maternal dyselectrolytemia will reflect
itself in the newborn. Thus, efforts should be made to
correct maternal electrolyte imbalance (here discussed,
hyponatremia) before delivery, particularly if local proto-
cols consider oral or IV fluids administration to shorten
labor; if maternal electrolyte correction is not possible
due to emergent delivery, it is anyway important to warn
the neonatologist about the type and gravity of maternal
metabolic derangement, so that appropriate monitoring
and timely correction of dyselectrolytemia may be per-
formed on the newborn after birth.
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